Steel Grove Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.6M Sell
21,625
-301
-1% -$34.8K 0.27% 38
2025
Q4
$2.31M Sell
21,926
-2,448
-10% -$230K 0.24% 41
2025
Q3
$1.93M Hold
24,374
0.23% 53
2025
Q2
$1.93M Buy
24,374
+21,146
+655% +$1.68M 0.23% 53
2025
Q1
$290K Sell
3,228
-120
-4% -$11.2K 0.04% 137
2024
Q4
$333K Sell
3,348
-2,595
-44% -$268K 0.05% 141
2024
Q3
$676K Sell
5,943
-205
-3% -$24.4K 0.09% 102
2024
Q2
$761K Sell
6,148
-17,768
-74% -$2.29M 0.11% 93
2024
Q1
$3.16M Buy
23,916
+790
+3% +$97.4K 0.42% 27
2023
Q4
$2.52M Sell
23,126
-978
-4% -$102K 0.34% 34
2023
Q3
$2.48M Sell
24,104
-548
-2% -$59.1K 0.33% 36
2023
Q2
$2.84M Buy
24,652
+1,885
+8% +$214K 0.36% 36
2023
Q1
$2.42M Sell
22,767
-2,798
-11% -$302K 0.32% 40
2022
Q4
$2.84M Buy
25,565
+212
+0.8% +$21.7K 0.4% 32
2022
Q3
$2.18M Sell
25,353
-589
-2% -$52.6K 0.39% 27
2022
Q2
$2.37M Buy
25,942
+21,977
+554% +$1.95M 0.43% 24
2022
Q1
$325K Buy
3,965
+56
+1% +$4.42K 0.05% 118
2021
Q4
$300K Sell
3,909
-282
-7% -$22.5K 0.06% 116
2021
Q3
$315K Buy
4,191
+1,088
+35% +$82.7K 0.07% 115
2021
Q2
$241K Buy
3,103
+193
+7% +$14.4K 0.07% 119
2021
Q1
$214K Hold
2,910
0.07% 123
2020
Q4
$227K Hold
2,910
0.07% 118
2020
Q3
$230K Hold
2,910
0.09% 100
2020
Q2
$215K Buy
+2,910
New +$219K 0.1% 103
2020
Q1
Sell
-22,760
Closed -$1.98M 123
2019
Q4
$1.98M Buy
22,760
+783
+4% +$64.3K 1.1% 20
2019
Q3
$1.76M Sell
21,977
-65
-0.3% -$5.21K 1.04% 21
2019
Q2
$1.76M Sell
22,042
-8,166
-27% -$625K 1.1% 21
2019
Q1
$2.4M Sell
30,208
-98,763
-77% -$7.39M 1.55% 14
2018
Q4
$9.47M Sell
128,971
-15,931
-11% -$1.12M 1.34% 13
2018
Q3
$9.88M Buy
144,902
+9,904
+7% +$631K 1.38% 9
2018
Q2
$7.88M Sell
134,998
-15,814
-10% -$892K 1.26% 12
2018
Q1
$7.91M Buy
150,812
+16,610
+12% +$897K 1.24% 14
2017
Q4
$7.27M Buy
134,202
+19,465
+17% +$1.08M 1.09% 35
2017
Q3
$7.06M Buy
114,737
+7,731
+7% +$469K 1.27% 15
2017
Q2
$6.57M Sell
107,006
-1,352
-1% -$82.3K 1.17% 31
2017
Q1
$6.62M Buy
108,358
+17,169
+19% +$1.04M 1.17% 23
2016
Q4
$5.16M Buy
91,189
+4,029
+5% +$236K 1.03% 30
2016
Q3
$5.23M Buy
87,160
+6,074
+7% +$355K 1.18% 18
2016
Q2
$4.49M Buy
81,086
+1,770
+2% +$94.2K 1.11% 22
2016
Q1
$4.04M Buy
79,316
+40,356
+104% +$1.98M 1.03% 35
2015
Q4
$1.98M Sell
38,960
-47,258
-55% -$2.38M 0.49% 67
2015
Q3
$4.1M Sell
86,218
-16,464
-16% -$875K 1.02% 34
2015
Q2
$5.62M Buy
102,682
+7,223
+8% +$405K 1.25% 22
2015
Q1
$5.28M Buy
+95,459
New +$5.41M 1.19% 32

Other funds holding MRK

Steel Grove Capital Advisors's MRK Position: Q1 2026 in Review

Steel Grove Capital Advisors reduced its Merck (MRK) stake by 1.4% in Q1 2026, selling an estimated $34.8K and leaving 21,625 shares worth $2.6M. The position accounts for 0.27% of the portfolio, ranked #38.

Steel Grove Capital Advisors first reported a position in MRK in Q1 2015 and has held it in 44 quarters since. The position peaked at $9.88M in Q3 2018. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Steel Grove Capital Advisors held 21,625 shares of Merck worth $2.6M as of Q1 2026.
  • Steel Grove Capital Advisors sold 301 Merck shares in Q1 2026, an estimated $34.8K.
  • Merck made up 0.27% of Steel Grove Capital Advisors's portfolio in Q1 2026, its #38 holding.
  • Steel Grove Capital Advisors first reported a position in Merck in Q1 2015 and has held it in 44 quarters since.
  • Steel Grove Capital Advisors's Merck position peaked at $9.88M in Q3 2018.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Steel Grove Capital Advisors's 13F filing for Q1 2026, filed 7 May 2026.